| RGNBX | RGNGX | RGNBX / RGNGX | |
| Total Expense Ratio | 1.40 | 0.34 | 412% |
| Annual Report Gross Expense Ratio | 1.40 | 0.34 | 412% |
| Fund Existence | 14 years | 14 years | - |
| Gain YTD | 2.041 | 2.202 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.9B | 21.9B | 100% |
| Annual Yield % from dividends | 0.99 | 1.93 | 51% |
| Returns for 1 year | 11.99 | 13.30 | 90% |
| Returns for 3 years | 40.43 | 45.12 | 90% |
| Returns for 5 years | 27.42 | 33.40 | 82% |
| Returns for 10 years | 87.66 | 97.53 | 90% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 42.20 | 0.28 | +0.67% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| DFSI | 44.91 | 0.13 | +0.29% |
| Dimensional International Sstby Cr 1 ETF | |||
| XTRE | 49.61 | 0.01 | +0.01% |
| BondBloxx Bloomberg ThreeYrTrgDurUSTrETF | |||
| JFLI | 52.15 | -0.02 | -0.05% |
| JPMorgan Flexible Income ETF | |||
| BGM | 2.39 | -0.55 | -18.71% |
| Qilian International Holding Group Ltd | |||